Prospect Capital Corpora... Stock Price - PBY

23.18
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
23.18
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Prospect Capital Corporaton PBY NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.16 -0.69% 23.18 23.00 23.28 23.11 23.34 16:00:02
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
22 3,613 $ 23.15 $ 83,631 4,742 11.69 - 26.77
Last Trade Time Type Quantity Stock Price Currency
18:30:00 100 $ 23.18 USD

Prospect Capital Corpora... Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.18B 50.79M 44.89M $ 22.24M $ - -1.37 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.65M $ - 674.07% - -

more financials information »

Prospect Capital Corpora... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PBY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week23.364723.999922.7323.558,936-0.1847-0.79%
1 Month22.614624.0022.5023.415,3070.56542.5%
3 Months25.6026.1011.6920.756,962-2.42-9.45%
6 Months25.7026.7711.6923.216,407-2.52-9.81%
1 Year25.1026.7711.6924.547,175-1.92-7.65%
3 Years25.2426.7711.6924.609,746-2.06-8.16%
5 Years25.2426.7711.6924.609,746-2.06-8.16%

Prospect Capital Corpora... Description

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.


Your Recent History
NYSE
PBY
Prospect C..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.